Prestigious Award Recognizes Pioneering Body's Defenses Research
The prestigious award in medical science has been awarded for revolutionary discoveries that illuminate how the immune system attacks dangerous infections while sparing the healthy tissues.
Three renowned scientists—Japan's Prof. Sakaguchi and US scientists Mary Brunkow and Fred Ramsdell—share this honor.
Their work identified specialized "security guards" within the immune system that remove rogue defense cells capable of harming the body.
These discoveries are now enabling innovative therapies for autoimmune diseases and malignancies.
These winners will share a monetary award valued at 11 million SEK.
Crucial Findings
"The work has been decisive for understanding how the body's defenses operates and the reason we do not all suffer from severe autoimmune diseases," stated the chair of the Nobel Committee.
The trio's research address a core mystery: In what way does the immune system defend us from numerous infections while leaving our healthy cells unharmed?
Our body's protection system employs white blood cells that scan for indicators of infection, even pathogens and germs it has not met before.
These cells employ sensors—called recognition units—that are generated randomly in a vast number of combinations.
That gives the immune system the capacity to combat a broad range of threats, but the randomness of the process inevitably creates white blood cells that can target the body.
Security Guards of the Immune System
Scientists previously knew that some of these harmful white blood cells were destroyed in the immune organ—where immune cells mature.
The latest Nobel Prize honors the identification of regulatory T-cells—described as the immune system's "peacekeepers"—which patrol the system to disarm other defenders that assault the healthy cells.
It is known that this process malfunctions in autoimmune diseases such as type-1 diabetes, MS, and rheumatoid arthritis.
The prize committee added, "These discoveries have laid the foundation for a new field of investigation and accelerated the creation of innovative therapies, for instance for tumors and immune disorders."
In malignancies, T-regs prevent the system from attacking the growth, so studies are focused on reducing their quantity.
In self-attack disorders, trials are exploring boosting regulatory T-cells so the body is no longer under attack. A comparable method could also be effective in minimizing the risks of organ transplant rejection.
Innovative Experiments
Prof Sakaguchi, from a Japanese institution, performed experiments on mice that had their immune gland extracted, leading to self-attack conditions.
He demonstrated that introducing defense cells from other mice could stop the illness—implying there was a system for blocking immune cells from harming the body.
Dr. Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Fred Ramsdell, currently at Sonoma Biotherapeutics in a California city, were investigating an genetic immune disorder in mice and humans that resulted in the discovery of a gene critical for how T-regs operate.
"Their groundbreaking research has uncovered how the immune system is controlled by regulatory T cells, stopping it from mistakenly attacking the healthy cells," commented a prominent physiology specialist.
"This work is a striking illustration of how fundamental biological study can have far-reaching consequences for public health."
